Search

Your search keyword '"Schiavon, G"' showing total 632 results

Search Constraints

Start Over You searched for: Author "Schiavon, G" Remove constraint Author: "Schiavon, G"
632 results on '"Schiavon, G"'

Search Results

1. Experimental Didactic Kit for Teaching Resistors, Capacitors and 'RC' Timing Circuits

3. BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population

4. Broadband downconversion in Eu2+,3+/Yb3+ doped calcium aluminosilicate glasses for solar cells applications.

7. Photoacoustic and photothermal and the photovoltaic efficiency of solar cells: A tutorial.

8. Thin-film of Nd3+–Yb3+ co-doped low silica calcium aluminosilicate glass grown by a laser deposition technique.

10. 187O Capivasertib and fulvestrant for patients (pts) with aromatase inhibitor (AI)-resistant HR+/HER2– advanced breast cancer (ABC): Subgroup analyses from the phase III CAPItello-291 trial

13. 458MO Efficacy of durvalumab (Durva) in combination with olaparib (Ola) and capivasertib (Cap) in patients (pts) with advanced or metastatic (met) cancers (Ca) (MEDIPAC)

24. Thin-film of Nd3+–Yb3+ co-doped low silica calcium aluminosilicate glass grown by a laser deposition technique

27. 515MO A phase I trial of durvalumab (Durv) in combination with olaparib (Ola) and capivasertib (Cap) in patients (pts) with advanced or metastatic cancers (Ca) (MEDIPAC)

39. 350TiP A phase III trial of capivasertib and fulvestrant versus placebo and fulvestrant in patients with HR+/HER2− breast cancer (CAPItello-291)

41. The potential of multifrequency polarimetric SAR in assessing agricultural and arboreous biomass

49. Corrigendum: Cetuximab rechallenge in metastatic colorectal cancer patients: How to come away from acquired resistance? [Ann Oncol, 23, 9, (2012) (2313-2318)] doi: 10.1093/annonc/mdr623

50. A Phase I Open-Label Study to Identify a Dosing Regimen of the Pan-AKT Inhibitor AZD5363 for Evaluation in Solid Tumors and in PIK3CA -Mutated Breast and Gynecologic Cancers

Catalog

Books, media, physical & digital resources